Glomerulonephritis, IGA
21
6
6
7
Key Insights
Highlights
Success Rate
78% trial completion
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 29/100
9.5%
2 terminated out of 21 trials
77.8%
-8.8% vs benchmark
29%
6 trials in Phase 3/4
43%
3 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (21)
Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
Study of the IgA Repertoire During IgA Deposition Nephropathy.
A Study of the Safety and Activity of Sparsentan for the Treatment of Patients With Immunoglobulin A Nephropathy
Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)
Interest of Follicular Helper Lymphocytes / Regulatory Follicular Helper Lymphocytes Ratio in IgA Nephropathy
A Study of Cemdisiran in Adults With Immunoglobulin A Nephropathy (IgAN)
Efficacy and Safety of Probiotics Combined With Enteric-coated Budesonide Capsules in Patients With Primary IgA Nephropathy
Efficacy of Immunosuppressive Therapy for IgA Nephropathy With Stage 3 or 4 CKD
Application of Hyperspectral Imaging in the Diagnosis of Glomerular Diseases
The Clinical Trial of ADR-001 for IgA Nephropathy
Trial of Plasma Exchange for Severe Crescentic IgA Nephropathy
Leflunomide Plus Low Dose Corticosteroid in Immunoglobulin A (IgA) Nephropathy With Renal Insufficiency
Efficacy and Safety of Losartan in Children With Ig A Nephropathy
A Controlled Study of Steroids Therapy for Patients of IgA Nephropathy With Active Pathological Changes.
Sirolimus Therapy for Poor Prognosis Immunoglobulin A Nephropathy
A Prospective Study of the Kidney Protective Effect of Aliskiren in Hypertensive Patients With IgA Nephropathy
Role of Regulatory T Cells in Pathogenesis of Primary IgA Nephropathy
Effects of Mycophenolate Mofetil (MMF) On Anti-HLA (Human Leukocyte Antigen)Antibody Levels In Patients Awaiting Cadaveric Renal Transplant.
Effects of Rituximab and Mycophenolate Mofetil (MMF) on Highly Sensitized Patients Awaiting Renal Transplant